Status: current, Defined. Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1479372013 | Cutaneous suspension | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3541795016 | Conventional release cutaneous suspension (dose form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3541796015 | Conventional release cutaneous suspension | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Conventional release cutaneous suspension | Is a | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
| Conventional release cutaneous suspension | Is a | Drug suspension | false | Inferred relationship | Some | ||
| Conventional release cutaneous suspension | Is a | Cutaneous dose form | true | Inferred relationship | Some | ||
| Conventional release cutaneous suspension | Has dose form administration method | Apply | true | Inferred relationship | Some | ||
| Conventional release cutaneous suspension | Has dose form intended site | Cutaneous | true | Inferred relationship | Some | ||
| Conventional release cutaneous suspension | Has dose form release characteristic | Conventional release | true | Inferred relationship | Some | ||
| Conventional release cutaneous suspension | Has basic dose form | Suspension | true | Inferred relationship | Some | ||
| Conventional release cutaneous suspension | Has dose form transformation | No transformation | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cutaneous suspension spray | Is a | False | Conventional release cutaneous suspension | Inferred relationship | Some | |
| Ciclopirox 0.77% topical suspension | Has manufactured dose form | False | Conventional release cutaneous suspension | Inferred relationship | Some | |
| Calcipotriene 0.005%/betamethasone 0.064% topical suspension | Has manufactured dose form | False | Conventional release cutaneous suspension | Inferred relationship | Some |
Reference Sets
Qualifier value foundation reference set
FHIR